|
Active substance |
tocilizumab |
|
Holder |
Roche |
|
Status |
Closed |
|
Indication |
Giant cell arteritis (GCA or temporal arteritis) |
|
Public documents |
|
|
Last update |
10/02/2020 |
RoActemra®
Last updated on 10/09/2024